Two-step screening for depressive symptoms in patients treated with kidney replacement therapies: a cross-sectional analysis.

ABSTRACT:

Background

Systematic screening for depressive symptoms may identify patients who may benefit from clinical assessment and psychosocial support. Here we assess a two-step screening using ultrabrief pre-screeners [Edmonton Symptom Assessment Survey-revised Depression item (ESASr-D) or Patient Health Questionnaire-2 (PHQ-2)] followed by the Patient-Reported Outcomes Measurement Information System Depression questionnaire (PROMIS-D) to identify depressive symptoms in patients on kidney replacement therapies.

Methods

We conducted a cross-sectional study of adults (kidney transplant recipients or treated with dialysis) in Toronto, ON, Canada. We simulated various two-step screening scenarios where only patients above a pre-screening cut-off score on the ESASr-D or PHQ-2 would mov

SUBMITTER: Dano S 

PROVIDER: S-EPMC10157790 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature